Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 55,378 | 68,667 | 65,230 | 53,097 | 47,972 |
| Operating Income | -55,378 | -68,667 | -65,230 | -53,097 | -47,972 |
| Interest Expense | 1,950 | 1,878 | 1,874 | 0 | 0 |
| Other Income | -550 | -131 | 357 | -1,512 | 0 |
| Pre-tax Income | -57,878 | -70,676 | -66,747 | -54,609 | -47,972 |
| Income Tax | 24 | -1,590 | 2,519 | -1,776 | -161 |
| Net Income Continuous | -57,902 | -69,086 | -69,266 | -52,833 | -47,811 |
| Net Income | $-57,902 | $-69,086 | $-69,266 | $-52,833 | $-47,811 |
| EPS Basic Total Ops | -4.32 | -5.12 | -5.20 | -4.24 | -3.84 |
| EPS Basic Continuous Ops | -4.30 | -5.14 | -5.21 | -4.26 | -3.86 |
| EPS Diluted Total Ops | -4.32 | -5.12 | -5.20 | -4.24 | -3.84 |
| EPS Diluted Continuous Ops | -4.30 | -5.14 | -5.21 | -4.26 | -3.86 |
| EBITDA(a) | $-54,315 | $-67,952 | $-64,895 | $-52,883 | $-47,959 |